Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 1.
The immunologic modulation of glutamate (Glu) neurotransmission is a topic of great interest. Neuroinflammation is an intrinsic component of neurodegenerative diseases, as well as a factor responsible for cognitive and behavioral changes. Cyclooxygenase-2 (COX-2) expression in the brain was shown to be associated with inflammation. COX-2 is also widely expressed in the brain including neurons and glia and participates in fundamental brain functions, e.g. in synaptic plasticity or memory consolidation. Furthermore, COX-2/Glu interplay has been reported, while metabotropic glutamate receptors (mGluRs) are known to contribute to plastic changes and to behavior. The primary goal of this study was to explain the behavioral consequences of the modulation of the glutamatergic pathway via the interaction of the mGlu5 receptor and COX-2, utilizing a panel of behavioral tests. To determine whether the glutamatergic pathway and COX-2 are involved in modulating the behavior of mice, C57B1/6 J and CD-1 male mice were injected daily with MTEP an mGluR5 antagonist, or a combination of MTEP and NS398 (COX-2 inhibitor) for 7 and 14 days. The following behavioral tests were used to screen for possible effects of the drug administration and interaction of the 2 compounds: the modified Barnes maze (MBM), stress-induced hyperthermia (SIH), Porsolt test (PT), tail suspension test (TST), modified rotarod (MR), and social interaction (SI) test. A time-dependent influence on spatial learning was found after the co-administration of MTEP and NS398. Furthermore, NS398 injected chronically amplified the antidepressant-like effects of MTEP in the PT and TST, and influenced the tolerance development observed after MTEP treatment in the SIH test.